PFS was significantly longer in the FOLFOX@ with cetuximab group compared with UFOX with cetuximab group ( median @ vs. @ months ; hazard ratio , @ ; @ % confidence interval -LSB- CI -RSB- , @-@ @ ; P = @ ) .